OPEN END TURBO LONG - RECORDATI INDUSTRIA CHIMICA E FARMA | Real-time Bid/Ask 12:47:07 20/06/2024 BST | ||
| 0.236 EUR / 0.244 EUR | +26.32% |
|
| Current month | -26.92% | ||
| 1 month | -61.22% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 20/06/24 | 0.212 | +11.58% |
| 19/06/24 | 0.19 | -23.69% |
| 18/06/24 | 0.249 | +43.93% |
| 17/06/24 | 0.173 | -21.00% |
| 14/06/24 | 0.219 | -24.48% |
Delayed Quote Börse Stuttgart
Last update June 20, 2024 at 08:31 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | ME73C6 |
| ISIN | DE000ME73C67 |
| Date issued | 17/01/2024 |
| Strike | 46.07 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.48 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.77 € |
|---|---|
| Lowest since issue | 0.173 € |
| Spread | 0.008 € |
| Spread % | 3.20% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
47.84
EUR
Average target price
52.64
EUR
Spread / Average Target
+10.03%
- Stock Market
- Certificates
- Certificat
